Leukocyte removal therapy for ulcerative colitis does not affect postoperative complications Authors
Received: 06 April 2006 Accepted: 23 July 2006 DOI:
Cite this article as: Ikeuchi, H., Yamamura, T., Kusunoki, M. et al. J Gastroenterol (2006) 41: 848. doi:10.1007/s00535-006-1875-1 Abstract Background
We investigated the incidence of postoperative complications in patients treated with or without preoperative leukocyte removal therapy (LRT).
The case notes of 387 patients with ulcerative colitis (UC) who underwent surgical intervention were retrospectively reviewed. One hundred nine patients were treated with LRT within 8 weeks before surgery (LRT group), and 278 had not received LRT since at least 8 weeks before surgery (without LRT group). We reviewed the postoperative complications according to type of initial operation.
Of the patients who underwent an ileal J-pouch anal anastomosis (IPAA) without an ileostomy, 3 (6.5%) in the LRT group developed pouch-related complications (PRC), while 11 (7.5%) in the without LRT group developed PRC. The overall postoperative complication rates were 28.3% in the LRT group and 21.8% in the without LRT group. For patients who underwent an IPAA with an ileostomy, the overall rates of postoperative complications were 39.1% in the LRT group and 31.8% in the without LRT group. Among those undergoing a total colectomy, 33.3% in the LRT group and 18.2% in the without LRT group had postoperative complications. No statistically significant differences were demonstrated between the two groups with respect to postoperative complications.
Our results suggest that preoperative LRT does not influence the rate of postoperative complications in UC patients.
Key words leukocyte removal therapy ulcerative colitis complications References
Wallance, D, Goldfinger, D, Lowe, C 1982 A double-blind controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis N Engl J Med 306 1406 10 CrossRef
Sawada, K, Ohnishi, K, Kosaka, T, Fukui, S, Yamamura, M, Amano, K, et al. 1995 Leukocytapheresis therapy with leukocyte removal filter for inflammatory bowel disease J Gastroenterol 30 124 7 PubMed
Sawada, K 2003 Leukocytapheresis as an adjunct to conventional medication for inflammatory bowel disease Dis Colon Rectum 46 66 77
Lightiger, S, Present, DH, Kornbluth, A, Gelernt, I, Bauer, J, Galler, G, et al. 1994 Cyclosporine in severe ulcerative colitis refractory to steroid therapy N Engl J Med 330 1841 5 CrossRef
Ikeuchi, H, Shoji, Y, Kusunoki, M, Yanagi, H, Noda, M, Yamamura, T 2003 Clinical result after restorative proctocolectomy without diverting ileostomy for ulcerative colitis Int J Colorectal Dis 19 234 8 PubMed CrossRef
Reding, R, Michel, LA, Donckier, J, De Canniere, L, Jamart, J 1990 Surgery in patients on long-term steroid therapy: a tentative model for risk assessment Br J Surg 77 1175 8 PubMed
Furst, MB, Stromberg, BV, Blatchford, GJ, Christensen, MA, Thorson, AG 1994 Colonic anastomosis: bursting strength after corticosteroid treatment Dis Colon rectum 37 12 5 PubMed CrossRef
Alstead, EM, Ritchie, JK, Leonark-Jones, JE, Farthing, MJ, Clark, ML 1990 Safety of azathiopurine in pregnancy in inflammatory bowel disease Gastroenterology 99 443 6 PubMed
Shimoyama, T, Sawada, K, Hiwatashi, N, Sawada, T, Matsueda, K, Munakata, A, et al. 2001 Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study J Clin Apher 16 1 9 PubMed CrossRef
Hanai, H, Watanabe, F, Saniabadi, AR, Matsushita, I, Takeuchi, K, Iida, T 2002 Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis Dig Dis Sci 47 2349 53 PubMed CrossRef
Sawada, K, Ohnishi, K, Kosaka, T, Chikano, S, Egashira, A, Izawa, H, et al. 1997 Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis Ther Apher 1 207 11 PubMed
Fukunaga, K, Fukuda, Y, Sawada, K, Hori, K, Matoba, Y, Sagayama, K, et al. 2003 Poorly controlled ulcerative colitis treated by colectomy during remission induced by extracorporeal leukocyte removal therapy J Gastroenterol 38 684 9 PubMed CrossRef
Sawada, K, Egashira, A, Ohnishi, K, Fukunaga, K, Kusaka, T, Shimoyama, T 2005 Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon Dig Dis Sci 50 767 73 PubMed CrossRef
Ziv, Y, Church, JM, Fazio, VW, King, TM, Lavery, IC 1996 Effect of systemic steroids on ileal pouch–anal anastomosis in patients with ulcerative colitis Dis Colon rectum 39 504 8 PubMed CrossRef
Pinna-Pintor, M, Arese, P, Bona, R, Falletto, E, Schieroni, R, Villata, E, et al. 2000 Severe steroid-unresponsive ulcerative colitis. Outcomes of restorative proctocolectomy in patients undergoing cyclosporine treatment Dis Colon Rectum 43 609 14 PubMed CrossRef
Hyde, GM, Jewell, DP, Kettlewell, MGW, Mortensen, NJMcC 2001 Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications Dis Colon Rectum 44 1436 40 PubMed CrossRef
Actis, GC, Ottobrelli, A, Pera, A, Barletti, C, Ponti, V, Pinna-Pintor, M, et al. 1993 Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids J Clin Gastroenterol 17 10 3 PubMed CrossRef
Fleshner, PR, Michelassi, F, Rubin, M, Hanauer, SB, Plevy, SE, Targan, SR 1995 Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin Dis Colon Rectum 38 1241 5 PubMed CrossRef
Yajima, T, Takaishi, H, Kanai, T, Iwao, Y, Watanabe, M, Ishii, H, et al. 1998 Predictive factors of response to leukocytapheresis therapy for ulcerative colitis Ther Apher 2 115 9 PubMed
Sawada, K, Kusugami, K, Suzuki, Y, Bamba, T, Munakata, A, Hibi, T, et al. 2005 Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment Am J Gastroenterol 100 1362 9 PubMed CrossRef
Nagase, K, Sawada, K, Ohnishi, K, Egashira, A, Ohkusu, K, Shimoyama, T 1998 Complication of leukocytapheresis Ther Apher 2 120 4 PubMed Copyright information
© Springer-Verlag Tokyo 2006